Hematology: Page 3

Hemanext submits blood cell processing device to FDA

Hemanext One was designed to process and store eligible RBCs with the goal of limiting oxygen and carbon dioxide exposure, two significant drivers of RBC damage, Hemanext said. The objective is to improve outcomes for patients with blood disorders and those in need of transfusions, the company said.

January 6, 2022

COVID-19 plays central role in LabPulse's top 10 stories for 2021

At the top of the list is a story on how unmanned aerial vehicles are being used to deliver diagnostic tests or essential medicines, especially in areas with high traffic or difficult-to-travel terrain. Drones are not yet a turnkey solution, but their utility in traversing challenging environments is being recognized as a way to transport everything from COVID-19 tests to blood products.

December 29, 2021

Video from ASH 2021: Sickle-cell patients, activists tell their stories

It was a different story at the American Society of Hematology (ASH) 2021 meeting. The society helped alleviate the financial burden that both patients and advocates face in attending meetings. One beneficiary was Teonna Woolford, a sickle cell warrior and co-founder/CEO of advocacy group Sickle Cell Reproductive Health Education Directive.

December 19, 2021

Video from ASH 2021: Advances in treating myeloid disorders

Sekeres is chief of the division of hematology at the Sylvester Comprehensive Cancer Center in Miami. He also serves as ASH's communications director. Sekeres' research interests are in leukemias, myelodysplastic syndromes, and myeloid malignancies.

December 14, 2021

Video from ASH 2021: Gene therapy 2.0: The latest in gene editing

The presentations compared new approaches to gene editing with more established approaches in the field, according to Leah Cepko, a science advisor with Science and Medicine Group, parent company of LabPulse.com. Click on the video below to learn more.

December 13, 2021

Video from ASH 2021: Why AI is no threat to pathologists

The workload for pathologists is increasing, even as the number of pathologists declines. AI offers a potential solution to this problem, according to Leah Sherwood and Leah Cepko, who were onsite reporting for LabPulse.com. Hear their views in the video below.

December 12, 2021

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

Patients prefer immediate test results, even when the news is bad

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Quest Diagnostics offers suite of services for transplant patients and living donors

90% is not good enough: How AI will reshape hemopathology

"The real question ... is to what extent is AI and computer vision going to be able to either help us or maybe supplant us," said Dr. Scott Rodig, PhD, of Brigham and Women's Hospital. Rodig chaired the session, which was titled "AI, Data Science, Computer Vision and the Hematology Laboratory of the Future."

December 12, 2021

Video from ASH 2021: COVID-19 pandemic takes center stage

Important topics at ASH 2021 have included how to keep the blood supply safe and secure during the pandemic, and how to treat patients with blood cancer who develop COVID-19. LabPulse.com editor Leah Sherwood is onsite in Atlanta and provides an update in this video.

December 11, 2021

Video from ASH 2021: Day 1 update

Leah Cepko, a science advisor at Science and Medicine Group, provides an update from the first day of the conference. Click on the video below to view.

December 11, 2021

Study recommends screening for adults at risk of multiple myeloma

"We know that in cancers such as breast cancer and lung cancer screening, early detection and early intervention can make a difference in patient survival," senior author Dr. Irene Ghobrial of the Dana-Farber Cancer Institute in Boston said in a statement. "We have shown for the first time that with highly sensitive screening techniques, it may eventually be possible to make a difference in the survival of people at elevated risk for multiple myeloma."

December 10, 2021

ASH 2021: What technologies will disrupt hematology diagnostics?

Changing how clinicians approach medicine

December 10, 2021

AAD secures BARDA contract for early sepsis detection test

QScout RLD+ can be used in urgent care clinics, doctor's offices, and other nonhospital settings, the company said. It is a rapid hematology analyzer that can describe a seven-part leukocyte differential, including quantifying band neutrophils and other immature granulocytes which can indicate severe infection. Results are available in two minutes compared to the two hours often required by a hospital's testing protocol, according to AAD.

October 5, 2021

Previous Page

Page 3 of 6

Next Page